Abbvie Inc [NYSE: ABBV] gained 4469761% or 7539814.45 points to close at $7540000.0 with a heavy trading volume of 4469761 shares.
It opened the trading session at $185.3, the shares rose to $187.085 and dropped to $184.64, the range by which the price of stock traded the whole day. The daily chart for ABBV points out that the company has recorded 8.09% gains over the past six months.
If we look at the average trading volume of 7.54M shares, ABBV reached to a volume of 4469761 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Abbvie Inc [ABBV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABBV shares is $213.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 1.87. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Abbvie Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 14, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 22, 2025, representing the official price target for Abbvie Inc stock. Previously, the target price had yet another raise to $191, while BofA Securities analysts kept a Neutral rating on ABBV stock.
The Price to Book ratio for the last quarter was 230.60, with the Price to Cash per share for the same quarter was set at 2.93. Price to Free Cash Flow for ABBV in the course of the last twelve months was 21.29 with Quick ratio for the last quarter at 0.64.
Trading performance analysis for ABBV stock
Abbvie Inc [ABBV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.05. With this latest performance, ABBV shares gained by 1.16% in over the last four-week period, additionally plugging by 8.09% over the last 6 months – not to mention a rise of 4.33% in the past year of trading.
Abbvie Inc [ABBV]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Abbvie Inc [ABBV] shares currently have an operating margin of 30.74% and a Gross Margin at 70.80%. Abbvie Inc’s Net Margin is presently recorded at 7.24%.
Return on Equity for this stock inclined to 2.92%, with Return on Assets sitting at 2.92%.
Abbvie Inc [ABBV]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABBV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbvie Inc go to 15.22%.
An analysis of Institutional ownership at Abbvie Inc [ABBV]
There are presently around $74.45%, or 74.53% of ABBV stock, in the hands of institutional investors. The top three institutional holders of ABBV stocks are: VANGUARD GROUP INC with ownership of 170.66 million shares, which is approximately 9.6472%. BLACKROCK INC., holding 136.43 million shares of the stock with an approximate value of $$23.4 billion in ABBV stocks shares; and BLACKROCK INC., currently with $$13.34 billion in ABBV stock with ownership which is approximately 4.398%.
